142 related articles for article (PubMed ID: 24662087)
1. Synthesis and biological activity of some bile acid-based camptothecin analogues.
Li X; Zhao T; Cheng D; Chu C; Tong S; Yan J; Li QY
Molecules; 2014 Mar; 19(3):3761-76. PubMed ID: 24662087
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of a series of lactone-opened camptothecin derivatives.
Zheng C; Li MZ; You TP; Tang WP; Lou LG
J Asian Nat Prod Res; 2019 Jan; 21(1):51-61. PubMed ID: 29063792
[TBL] [Abstract][Full Text] [Related]
4. Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.
Ishikawa T; Ikegami Y; Sano K; Nakagawa H; Sawada S
Curr Pharm Des; 2006; 12(3):313-25. PubMed ID: 16454746
[TBL] [Abstract][Full Text] [Related]
5. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Fox ME; Guillaudeu S; Fréchet JM; Jerger K; Macaraeg N; Szoka FC
Mol Pharm; 2009; 6(5):1562-72. PubMed ID: 19588994
[TBL] [Abstract][Full Text] [Related]
7. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity.
Zhang Z; Tanabe K; Hatta H; Nishimoto S
Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173
[TBL] [Abstract][Full Text] [Related]
8. Camptothecin analogues with enhanced antitumor activity at acidic pH.
Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
[TBL] [Abstract][Full Text] [Related]
9. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC
Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin.
Gao H; Zhang X; Chen Y; Shen H; Sun J; Huang M; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Apr; 15(8):2003-6. PubMed ID: 15808456
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of novel 20s-camptothecin analogues.
Li Q; Lv H; Zu Y; Qu Z; Yao L; Su L; Liu C; Wang L
Bioorg Med Chem Lett; 2009 Jan; 19(2):513-5. PubMed ID: 19056266
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
14. Transporter-Targeted Bile Acid-Camptothecin Conjugate for Improved Oral Absorption.
Xiao L; Zhou Y; Zhang X; Ding Y; Li Q
Chem Pharm Bull (Tokyo); 2019 Oct; 67(10):1082-1087. PubMed ID: 31391385
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of 20-O-linked nitrogen-based camptothecin ester derivatives.
Wang CY; Pan XD; Liu HY; Fu ZD; Wei XY; Yang LX
Bioorg Med Chem; 2004 Jul; 12(13):3657-62. PubMed ID: 15186850
[TBL] [Abstract][Full Text] [Related]
16. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacology of new camptothecin drugs.
Driver RW; Yang LX
Mini Rev Med Chem; 2005 May; 5(5):425-39. PubMed ID: 15892685
[TBL] [Abstract][Full Text] [Related]
18. Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.
Li M; Tang W; Zeng F; Lou L; You T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6441-3. PubMed ID: 18986807
[TBL] [Abstract][Full Text] [Related]
19. Novel C-ring analogues of 20(S)-camptothecin. Part 3: synthesis and their in vitro cytotoxicity of A-, B- and C-ring analogues.
Subrahmanyam D; Sarma VM; Venkateswarlu A; Sastry TV; Srinivas AS; Krishna CV; Deevi DS; Kumar SA; Babu MJ; Damodaran NK
Bioorg Med Chem Lett; 2000 Feb; 10(4):369-71. PubMed ID: 10714502
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer.
Zhou L; Li X; Chen X; Li Z; Liu X; Zhou S; Zhong Q; Yi T; Wei Y; Zhao X; Qian Z
Cancer Lett; 2010 Nov; 297(1):56-64. PubMed ID: 20546992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
